# Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome

> **NCT00542763** · PHASE1 · COMPLETED · sponsor: **University Hospital Muenster** · enrollment: 12 (actual)

## Conditions studied

- Primary Sjogren's Syndrome

## Interventions

- **DRUG:** Mycophenolate sodium

## Key facts

- **NCT ID:** NCT00542763
- **Lead sponsor:** University Hospital Muenster
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** —
- **Final completion:** 2007-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2007-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00542763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00542763, "Mycophenolate Sodium Treatment in Patients With Primary Sjogren's Syndrome". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00542763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*